Bioelectronics Corp (BIEL)

[TAZZER]

BIEL not diluting at this point tells me they are encouraged by the FDA meeting and are think approval is around the corner. Otherwise, you are right they would take the 75K and cover costs for the upcoming month. I think no one trusts the FDA and people are thinking it is years out from approval. That is why the price is so so low. I have been here through the whole FDA process and I honestly think it is coming really soon. 400+ days and counting on 510K.

The market is there and when they spend adequate money on marketing this product it is going to take off like a rocket. The US is where 80% of the pain management device market. Actipatch is going to take a nice share of it... "Pain Management Devices Market worth 4.64 Billion USD by 2021". If BIEL takes 5% of it that would be $ 250 million in sales. That's why I am long on BIEL.